GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amplitude Surgical (XPAR:AMPLI) » Definitions » YoY EBITDA Growth

Amplitude Surgical (XPAR:AMPLI) YoY EBITDA Growth : 24.58% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Amplitude Surgical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Amplitude Surgical's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 24.58%.

Amplitude Surgical's EBITDA per Share for the six months ended in Dec. 2023 was €0.22.


Amplitude Surgical YoY EBITDA Growth Historical Data

The historical data trend for Amplitude Surgical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplitude Surgical YoY EBITDA Growth Chart

Amplitude Surgical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.77 -15.46 -3.60 43.68 -23.80

Amplitude Surgical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.58 67.90 -21.49 -19.49 24.58

Amplitude Surgical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Amplitude Surgical's YoY EBITDA Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (A: Jun. 2023 )
=(EBITDA per Share (A: Jun. 2023 )-EBITDA per Share (A: Jun. 2022 ))/ | EBITDA per Share (A: Jun. 2022 ) |
=(0.381-0.5)/ | 0.5 |
=-23.80 %

Amplitude Surgical's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(0.223-0.179)/ | 0.179 |
=24.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amplitude Surgical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Amplitude Surgical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Amplitude Surgical (XPAR:AMPLI) Business Description

Traded in Other Exchanges
Address
11 cours Jacques Offenbach, Valence, FRA, 26000
Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.

Amplitude Surgical (XPAR:AMPLI) Headlines

No Headlines